HIV-related Accelerated Aging of the Airway Epithelium

Status: Completed
Location: See location...
Study Type: Observational
SUMMARY

In cigarette smokers that are HIV+, one of the most common HIV-associated non-AIDS conditions is the accelerated development of chronic obstructive pulmonary disease (COPD), a disorder associated with significant morbidity and mortality. Based on the knowledge that COPD in smokers starts in the small airway epithelium, this study is focused on examining the hypothesis that the accelerated development of COPD associated with HIV infection results, in part, from an interaction of HIV directly on the small airway epithelium or through infection of cellular components of the immune system, with mediators released by these immune cells evoking premature biologic aging of the small airway epithelium. By identifying the early events in the pathogenesis of the HIV-associated accelerated COPD in smokers, we aim to identify biologic targets to which pharmacologic therapies could be addressed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ HEALTHY VOLUNTEER RESEARCH SUBJECTS

• All study subjects should be able to provide informed consent

• Males or females ages 18 years and older

• Must provide HIV informed consent

⁃ VOLUNTEER RESEARCH SUBJECTS WITH LUNG DISEASE

• Must provide informed consent

• Males and females age 18 years and older

• Lung disease proven by at least one of the following: symptoms consistent with pulmonary disease; (2) chest X-rays consistent with lung disease; (3) pulmonary function tests consistent with lung disease; (4) lung biopsy consistent with lung disease; (5) family history of lung disease; and/or (6) diseases of organs with known association with lung disease

• Must provide HIV informed consent

Locations
United States
New York
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
New York
Time Frame
Start Date: 2013-12-23
Completion Date: 2019-02-14
Participants
Target number of participants: 330
Treatments
Healthy nonsmokers
Healthy nonsmokers
Healthy smokers
Healthy smokers
COPD smokers
COPD smokers
Sponsors
Leads: Weill Medical College of Cornell University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov